Yun Teng Johnson

Title: Innovations of Yun Teng Johnson

Introduction

Yun Teng Johnson is a notable inventor based in Glendale, Wisconsin. He has made significant contributions to the field of pharmacology, particularly in the development of GABAergic receptor subtype selective ligands. His work focuses on creating pharmaceutical compositions that aim to treat various neurological disorders.

Latest Patents

Yun Teng Johnson holds 2 patents. His latest patents include innovations related to GABAergic receptor subtype selective ligands and their uses. These patents describe the development of α3 or α2 or α2/α3 GABAergic receptor subtype selective ligands, which are designed to treat anxiety disorders, epilepsy, and schizophrenia. Importantly, these ligands are formulated to have reduced sedative and ataxic side effects. The ligands lack ester linkages, making them relatively insensitive to hydrolysis by esterases, which enhances their therapeutic potential.

Career Highlights

Yun Teng Johnson is affiliated with the UWM Research Foundation, Inc., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on treating complex neurological conditions.

Collaborations

He has collaborated with notable colleagues, including Jie Yang and Michael Ming-Jin Poe, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yun Teng Johnson's contributions to the field of pharmacology through his innovative patents highlight his commitment to improving treatments for neurological disorders. His work exemplifies the importance of research and collaboration in advancing medical science.